总斑块面积与斑块回声特征:系统性红斑狼疮亚临床动脉粥样硬化的新指标
泼尼松龙治疗与较高TPA及较高回声相关,持续疾病活动与较高回声相关。
要点
- SLE患者中总斑块面积与斑块回声特征同斑块存在及IMT受不同因素影响。
- 泼尼松龙治疗与较高总斑块面积及斑块回声增强相关。
- 持续疾病活动与斑块回声增强相关。
核心结论
- SLE患者的总斑块面积和斑块回声特征与斑块存在及IMT的相关因素不同,纵向研究可能揭示这些指标在SLE心血管风险管理中的附加价值。
主要发现
- 年龄增长与斑块存在及IMT增加相关。
- 甘油三酯水平与斑块存在相关。
- TPA均值(标准差)为60.8(41.6)mm²。
- 服用泼尼松龙的患者TPA更高;多数斑块为低回声,但回声增强与泼尼松龙治疗及持续疾病活动相关。
临床怎么用
- 在SLE亚临床动脉粥样硬化评估中,除斑块存在和IMT外,可关注总斑块面积与斑块回声特征,并注意泼尼松龙治疗及持续疾病活动与这些指标的关联。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with SLE have an increased risk of developing cardiovascular disease (CVD). Multiple studies have shown that these patients have increased numbers of carotid plaques and greater intima-media thickness (IMT) than healthy controls. Measures such as total plaque area (TPA) and plaque echogenicity may be more sensitive and more relevant to cardiovascular risk than presence of plaque and IMT alone. Our objective was to produce the first report of TPA and echogenicity in a population of patients with SLE. METHODS: One hundred patients with SLE and no history of clinical CVD were recruited. Clinical, serological and treatment variables were recorded and serum was tested for antibodies to apolipoprotein A-1 and high-density lipoprotein. Both carotid and both femoral artery bifurcations of each patient were scanned to determine IMT, TPA and echogenicity of plaques. Univariable and multivariable statistical analyses were carried out to define factors associated with each of these outcomes. RESULTS: Thirty-six patients had carotid and/or femoral plaque. Increasing age was associated with presence of plaque and increased IMT. Triglyceride levels were associated with presence of plaque. Mean (s.d.) TPA was 60.8 (41.6) mm2. Patients taking prednisolone had higher TPA. Most plaques were echolucent, but increased echogenicity was associated with prednisolone therapy and persistent disease activity. CONCLUSION: TPA and plaque echogenicity in patients with SLE are associated with different factors than those associated with presence of plaque and IMT. Longitudinal studies may show whether these outcome measures add value in the management of cardiovascular risk in SLE.
引用
- Croca SC, Griffin M, Farinha F, et al. Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2021. PMID: 33404639. doi:10.1093/rheumatology/keaa905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。